Scientists have developed an antibody treatment that shows promise in blocking the potentially deadly effects of fentanyl for nearly a month, raising hopes for a new tool to combat overdoses.
Dec 6, 2023
0
15
Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...
Sep 18, 2023
1
46
For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important ...
Oct 17, 2022
0
52
A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.
Feb 1, 2022
0
182
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...
Jul 15, 2020
0
314
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers, including ...
Aug 1, 2019
0
337
Anaphylactic shock, an exacerbated allergic reaction that can prove fatal, is sometimes caused by the use of drugs during surgery. In most of these extreme reactions, evidence can be provided that patients have anti-drug ...
Jul 10, 2019
0
65
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...
Sep 13, 2017
0
69
The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...
May 4, 2016
0
82
People taking an experimental drug called Repatha (evolocumab) for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins, researchers said Sunday.
Mar 15, 2015
4
131
